The information on this website is for educational purposes only. Do not act or rely upon the information on this website without seeking independent professional medical advice.  Prolotherapy is a medical technique. As with any medical technique, results will vary among individuals, and there is no guarantee that you will receive the same outcome as patient reports here. Prolotherapy injections may not work for you and as with all medical procedures there are risks involved. These risks should be discussed with a qualified health care professional prior to any treatment so that you have proper informed consent and understand that there are no guarantees to healing.

Epicondylitis and Elbow Pain

Ongoing Positive Effect of Platelet Rich Plasma vs. Cortisone Injection in Lateral Epicondylitis: A Double Blind Controlled Trial With 2 year Follow Up. (2011)
Reduction of pain and increase in function was significant for patients in this trial study even after two years and especially as compared to those receiving cortisone. 

Hemwall-Hackett Dextrose Prolotherapy for Unresolved Elbow Pain. (2009)
This retrospective pilot study demonstrates improvement in pain, stiffness and quality of life for individuals treated with Prolotherapy for elbow pain. 

A Systematic Review of Four Injection Therapies for Lateral Epicondylosis:  Prolotherapy, Polidocanol, Whole Blood and Platelet-Rich Plasma (2009).
All four therapies were found to be effective in the treatment of lateral elbow pain.

The Efficacy of Prolotherapy for Lateral Epicondylosis: A Pilot Study. (2008)
In this double blind randomized controlled trial Dextrose Prolotherapy was well tolerated and dramatically improved pain and strength in patients with lateral elbow pain as compared to controls.

Treatment of Chronic Elbow Tendonosis with Buffered Platelet Rich Plasma. (2006)
This is the first published study (Mishra at Stanford University) studying the nonsurgical use of platelet rich plasma for elbow tendonosis. At final follow up 
(12-38 months) patients reported a 93% reduction in pain compared to prior to treatment.